MOLECULAR INSIGHT PHARMACEUTICALS
Molecular Insight Pharmaceuticals is a biopharmaceutical company specializing in the emerging field of molecular medicine, applying innovations in the identification and targeting of disease at the molecular level to improve patient healthcare by addressing significant unmet medical needs. They are focused on discovering, developing and commercializing innovative and targeted radiotherapeutics and molecular imaging pharmaceuticals with initial applications in the areas of oncology and cardiology.
MOLECULAR INSIGHT PHARMACEUTICALS
Industry:
Biotechnology Health Care
Founded:
1997-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.molecularinsight.com
Total Employee:
51+
Status:
Active
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Current Employees Featured
Stock Details
Official Site Inspections
http://www.molecularinsight.com
- Host name: 196.133.155.104.bc.googleusercontent.com
- IP address: 104.155.133.196
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Molecular Insight Pharmaceuticals"
Molecular Insight Pharmaceuticals - Crunchbase
Molecular Insight Pharmaceuticals is a biopharmaceutical company specializing in the emerging field of molecular medicine, applying innovations in the …See details»
Molecular Insight Pharmaceuticals - LinkedIn
Molecular Insight Pharmaceuticals, Inc. develops therapeutic radiopharmaceuticals and molecular imaging agents for use in oncology and cardiology. The company targets the development of a small ...See details»
Molecular Insight Pharmaceuticals Inc. (Nasdaq: MIPI)
Jan 1, 2003 The company is focused on discovering, developing and commercializing innovative and targeted radiotherapeutics and molecular imaging pharmaceuticals with initial applications …See details»
Molecular Insight Inc. - About Us
Molecular Insight Inc. - About Us ... 日本語See details»
Molecular Insight Pharmaceuticals, Inc. - Drug pipelines, Patents ...
Explore Molecular Insight Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 24 clinical trials, 2 news, and 26 literature, Drug:Iobenguane I-131, …See details»
Molecular Insight Inc.
株式会社モレキュラーインサイト. お問い合わせ： [email protected] ©2024-2025 Molecular Insight Inc. 無断転載・複写を禁止します。See details»
Molecular Insight Pharmaceuticals Overview - SignalHire
Molecular Insight Pharmaceuticals is a private company. The company currently specializes in the Pharmaceuticals area. Its headquarters is located at New York, New York, USA ...See details»
Organization | Molecular Insight Pharmaceuticals - Purdue University
Organization Overview. First Clinical Trial. 2006 NCT00339131. First Marketed Drug. None First NDA Approval. None ... Molecular Insight Pharmaceutical Employee | Molecular Insight …See details»
Molecular Insight Inc. - Our Team
Our team consists of members who can bridge the gap between chemistry and optics, research and manufacturing.See details»
Molecular Insight Pharmaceuticals CEO, Founder, Key Executive …
He served as Chairman & CEO of Molecular Insight Pharmaceuticals, Inc., where he led the organization from nascent stage through its position as a public company focused on the …See details»
Molecular Insight Pharmaceuticals, Inc. - Dun & Bradstreet
Company Description: Molecular Insight Pharmaceuticals (MIP) is working to make cancer invisible. The development-stage company is focused on making molecular imaging and …See details»
Molecular Insight Pharmaceuticals - PitchBook
Apr 14, 2005 Molecular Insight Pharmaceuticals General Information Description. Developer of small-molecule chemistry platform intended to improve the lives of patients through timely and …See details»
Molecular Insight Pharmaceuticals, Inc. - insights.citeline.com
Apr 3, 2017 Latest on Molecular Insight Pharmaceuticals, Inc. Already A Biomedtracker Subscriber? You have access to the full company record through your subscription. Go To …See details»
Molecular Insight Pharmaceuticals - Products, Competitors, …
Progenics Acquires Molecular Insight Pharmaceuticals to Expand Oncology-Focused Pipeline Nasdaq:PGNX. Jan 30, 2017. Progenics Acquires Molecular Insight Pharmaceuticals to …See details»
Molecular Insight Pharmaceuticals, Inc. Appoints John W. Babich, …
Sep 26, 2008 Molecular Insight Pharmaceuticals (NASDAQ: MIPI) is a biopharmaceutical company specializing in the emerging field of molecular medicine, applying innovations in the …See details»
Molecular Insight Inc. - English (Provisional Version)
We have started to develop technologies for non-destructive, non-contact, real-time analysis of the concentration, molecular structure, bonding species, and chemical environment of …See details»
Molecular Insight Pharmaceuticals, Inc. (Molecular Insight ...
了解Molecular Insight Pharmaceuticals, Inc. (Molecular Insight Pharmaceuticals, Inc.)公司的药物管线，治疗领域，技术平台，以及它的24项临床试验, 2篇新闻和25篇文献，疾病领域:肿瘤， …See details»
Molecular Insight Pharmaceuticals - Contacts, Employees, Board …
Molecular Insight Pharmaceuticals has 1 current employee profile, Vice President, Human Resources Lee Merill. Lee Merill Vice President, Human Resources Browse By: …See details»
Press Release: Molecular Insight Pharmaceuticals Acquires Drug ...
Jan 17, 2007 The company's website is: www.molecularinsight.com. Contact: Molecular Insight Pharmaceuticals, Inc. Priscilla Harlan, 617-492-5554 Vice President, Corporate …See details»
Progenics buys Molecular Insight Pharma to expand oncology …
Jan 23, 2013 Under the terms of the all-stock transaction, Progenics exchanged 4,566,210 shares of its common stock (8.9% of the total outstanding post-transaction shares) for all of …See details»